Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2014
05/15/2014WO2014074715A1 Cyclopropyl amide derivatives
05/15/2014WO2014074700A1 Antagonists of gpr119 receptor and the treatment of disorders related thereto
05/15/2014WO2014074675A1 Heteroaryl substituted pyridyl compounds useful as kinase modulators
05/15/2014WO2014074670A1 ALKYL AMIDE-SUBSTITUTED PYRIMIDINE COMPOUNDS USEFUL IN THE MODULATION OF IL-12, IL-23 AND/OR IFNα
05/15/2014WO2014074668A1 Modulators of gpr119 and the treatment of disorders related thereto
05/15/2014WO2014074661A1 AMIDE-SUBSTITUTED HETEROCYCLIC COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHα RESPONSES
05/15/2014WO2014074660A1 ALKYL-AMIDE-SUBSTITUTED PYRIDYL COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFNα RESPONSES
05/15/2014WO2014074658A1 Macrocyclic compounds for inhibition of inhibitors of apoptosis
05/15/2014WO2014074657A1 Bicyclic heterocycle substituted pyridyl compounds useful as kinase modulators
05/15/2014WO2014074628A1 Compounds for treating hiv and methods for using the compounds
05/15/2014WO2014074605A1 Preserved topical formulations with improved antimicrobial activity
05/15/2014WO2014074604A2 Combination therapy for hepatitis c virus infection
05/15/2014WO2014074593A1 Vegetable oil composition for reducing plasma cholesterol
05/15/2014WO2014074591A1 White keratin compositions
05/15/2014WO2014074584A1 On-demand drug release using magneto-electric nanoparticles
05/15/2014WO2014074580A1 Combination therapy
05/15/2014WO2014074552A2 Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
05/15/2014WO2014074529A1 Methods for treatment of primary cancer and cancer metastasis
05/15/2014WO2014074471A1 Methods for treating inflammatory diseases and pharmaceutical combinations useful therefor
05/15/2014WO2014074422A1 Amino-pyridine-containing spleen tyrosine kinase (syk) inhibitors
05/15/2014WO2014074421A1 Prodrug bipyridylaminopyridines as syk inhibitors
05/15/2014WO2014074309A1 Composition and use of hydrogenated alkyl ketene dimers
05/15/2014WO2014074289A1 Delivery of biologically-active agents using volatile, hydrophobic solvents
05/15/2014WO2014074218A1 Compounds and methods for producing a conjugate
05/15/2014WO2014074017A1 New medicinal composition for pain management in the case of smooth muscle spasm
05/15/2014WO2014074007A1 Dermatological composition with indicator properties
05/15/2014WO2014073989A1 Salt and polymorphic forms of (3r,4s)-l-((4-amino-5h-pyrrolo[3,2-d]pyrimidin-7-yl)methyl)-4(methylthiomethyl)pyrodin-3-ol(mtdia)
05/15/2014WO2014073904A1 Gpr40 receptor agonist, methods of preparing the same, and pharmaceutical compositions containing the same as an active ingredient
05/15/2014WO2014073889A1 Solid dispersions of insoluble drug and preparation method thereof
05/15/2014WO2014073740A1 Anti-cancer drug and treatment method for treating tumors having multidrug resistance
05/15/2014WO2014073659A1 Oral administration composition for ameliorating or preventing hypertension
05/15/2014WO2014073646A1 Periostin expression inhibitor comprising shikonin derivative
05/15/2014WO2014073447A1 Polymeric compound having camptothecin compound and anti-cancer effect enhancer bound thereto, and use of same
05/15/2014WO2014073209A1 Therapeutic agent for keratoconjunctive disorders
05/15/2014WO2014072985A1 Novel boronic acid derivatives as anti cancer agents
05/15/2014WO2014072967A1 Drug combination comprising a glycolysis inhibitor and a tyrosine kinase inhibitor
05/15/2014WO2014072957A1 Thiazole derivatives as alpha 7 nachr modulators
05/15/2014WO2014072956A1 Oxazolidin-2-one-pyrimidine derivatives
05/15/2014WO2014072937A1 Pharmaceutical compositions containing a pde4 inhibitor and a pi3 delta or dual pi3 delta-gamma kinase inhibitor
05/15/2014WO2014072911A1 Substituted indole derivatives
05/15/2014WO2014072903A1 Novel aminomethyl-phenol derivatives as antimalarial agents
05/15/2014WO2014072882A1 Heteroaromatic compounds as dopamine d1 ligands
05/15/2014WO2014072881A1 Heteroaromatic compounds and their use as dopamine d1 ligands
05/15/2014WO2014072747A1 Dermal compositions containing unnatural hygroscopic amino acids
05/15/2014WO2014072714A1 Novel histone deacetylase inhibitors and their use in therapy
05/15/2014WO2014072673A1 Fixed dose pharmaceutical composition comprising deferasirox and deferipone
05/15/2014WO2014072647A1 Co-micronisation product comprising a selective progesterone-receptor modulator
05/15/2014WO2014072646A1 Co-micronisation product comprising ulipristal acetate
05/15/2014WO2014072585A1 Ligneous plant-derived heteropolysaccharides for use in treatment of urologic symptoms and diseases
05/15/2014WO2014072525A1 Metal(iii)-polypeptide complexes
05/15/2014WO2014072498A1 1-[1-(benzoyl)-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonitrile derivatives
05/15/2014WO2014072493A1 Pharmaceutical combination comprising a b-raf inhibitor and a histone deacetylase inhibitor and their use in the treatment of proliferative diseases
05/15/2014WO2014072486A1 New benzene sulfonamide thiazole compounds
05/15/2014WO2014072468A1 Compositions for pulmonary delivery
05/15/2014WO2014072435A1 Substituted tricyclic benzimidazoles as kinase inhibitors
05/15/2014WO2014072419A1 Novel anti-hiv compounds
05/15/2014WO2014072380A1 Use of nad and ss-nad as a bronchodilator
05/15/2014WO2014072371A1 Indole derivatives, pharmaceutical compositions containing such indoles and their use as dna methylation modulators
05/15/2014WO2014072357A1 Combination for use in treating diseases or conditions associated with melanoma, or treating diseases or conditions associated with activated b-raf pathway
05/15/2014WO2014072350A1 N-acetyl-l-cysteine for use in in vitro fertilization
05/15/2014WO2014072330A1 Glucose responsive hydrogel comprising pba-grafted hyaluronic acid (ha)
05/15/2014WO2014072325A1 [3-heteroaryl-2-trifluoromethyl-propyl]-piperidin-1-yle or -morpholin-4-yle compounds as trpa1 antagonists for the treatment of respiratory diseases
05/15/2014WO2014072315A1 Powder composition for disinfection of the teats of dairy animals
05/15/2014WO2014072311A1 Medicament comprising at least one omega-3 polyunsaturated fatty acid
05/15/2014WO2014072261A1 Triazolo compounds
05/15/2014WO2014072259A1 Composition
05/15/2014WO2014072245A1 Levonorgestrel-only-composition for optimized oral contraception with defined levonorgestrel content, dosage regimen and pharmaceutical preparation
05/15/2014WO2014072244A1 Sulfoximine substituted quinazolines for pharmaceutical compositions
05/15/2014WO2014072230A1 Compositions for vaginal use containing tamarind polysaccharides
05/15/2014WO2014072220A1 Substituted pyrimidinyl and pyridinyl-pyrrolopyridinones, process for their preparation and their use as kinase inhibitors
05/15/2014WO2014071863A1 Use of benzonitrile compounds in preparing medicaments for treating tumor
05/15/2014WO2014071832A1 Alk kinase inhibitors
05/15/2014WO2014071824A1 4-quinazolinamine heterocyclic compound and use thereof
05/15/2014WO2014071819A1 Use of lanthanum acetate or hydrates thereof for treating hyperphosphatemia
05/15/2014WO2014071772A1 Pyrroloquinoline quinine disodium salt crystal
05/15/2014WO2014071757A1 Sevelamer carbonate medicinal tablet composition and preparation method thereof
05/15/2014WO2014071512A1 Combination therapy and methods for the treatment of respiratory diseases
05/15/2014WO2014071506A1 Compounds for reducing glucocorticoids, and methods of treatment thereof
05/15/2014WO2014071499A1 Pharmaceutical compositions comprising hydromorphone and naloxone
05/15/2014WO2014071480A1 Pharmaceutical compositions containing a fraction obtained from rhizophora mangle extract and use thereof
05/15/2014WO2014071457A1 Dual action nitric oxide donors and their use as antimicrobial agents
05/15/2014WO2014071449A1 Neuroactive steroids and their use to facilitate neuroprotection
05/15/2014WO2014071438A1 Modified polyphenols and modified polyphenol compositions
05/15/2014WO2014052935A3 Combination of rasagiline and pridopidine for treating neurodegenerative disorders, in particular huntington's disease
05/15/2014WO2014047232A3 C-rel inhibitors and uses thereof
05/15/2014WO2014031204A3 Carbohydrate-selective receptors
05/15/2014WO2014027979A3 Tablet formulations comprising tadalafil and dapoxetine
05/15/2014WO2013149258A8 Compositions and methods for treating or preventing metabolic syndrome disorders
05/15/2014WO2013142124A8 Solid forms of a thiophosphoramidate nucleotide prodrug
05/15/2014WO2013052587A3 Methods for identifying and treating an individual with an inflammatory disease using fatty acid-based therapies
05/15/2014WO2013052550A3 Novel imidazole quinoline-based immune system modulators
05/15/2014WO2013049770A3 Methods of treating cancer
05/15/2014WO2013009800A3 Compositions of alkylating agents and methods of treating skin disorders therewith
05/15/2014US20140135529 Method for administering an nmda receptor antagonist to a subject
05/15/2014US20140135487 Immunostimulatory g, u-containing oligoribonucleotides
05/15/2014US20140135486 Multi-arm polyethylene glycol derivatives, conjugates and gels of pharmaceuticals and the same
05/15/2014US20140135485 6-11 bicyclic ketolide derivatives
05/15/2014US20140135414 Preparation of polymerizable compositions
05/15/2014US20140135403 Use of cyclohexanehexol derivatives in the treatment of ocular diseases
05/15/2014US20140135398 Antioxidant Producing Bacterium and Uses Thereof
1 ... 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 ... 7860